Oncology Institute Inc. (TOI)
NASDAQ: TOI
· Real-Time Price · USD
2.92
0.17 (6.18%)
At close: May 08, 2025, 3:59 PM
2.95
1.03%
After-hours: May 08, 2025, 07:55 PM EDT
6.18% (1D)
Bid | 2.48 |
Market Cap | 221.2M |
Revenue (ttm) | 393.41M |
Net Income (ttm) | -61.05M |
EPS (ttm) | -0.71 |
PE Ratio (ttm) | -4.11 |
Forward PE | n/a |
Analyst | Buy |
Ask | 3.15 |
Volume | 1,090,692 |
Avg. Volume (20D) | 941,537 |
Open | 2.72 |
Previous Close | 2.75 |
Day's Range | 2.71 - 3.09 |
52-Week Range | 0.13 - 3.50 |
Beta | 0.07 |
Analyst Forecast
According to 0 analyst ratings, the average rating for TOI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+24.47%
The Oncology Institute shares are trading higher f...
Unlock content with
Pro Subscription
5 months ago
-23.47%
The Oncology Institute shares are trading lower. The stock may be moving on continued weakness following worse-than-expected Q3 financial results reported on Wednesday.

1 month ago · seekingalpha.com
The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call TranscriptThe Oncology Institute, Inc. (NASDAQ:TOI ) Q4 2024 Earnings Conference Call March 25, 2025 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO Rob Carter - CFO C...